Shonukan O, Dantzig A, Kloeker-Rhoades S, Garcia-Ribas I. Development of LY2334737, an oral gemcitabine prodrug for continuous administration. Perspectives for the therapy of mature T-cell and NK-cell lymphomas. Hematol Meeting Rep [Internet]. 2009 Jun. 11 [cited 2024 Nov. 23];3(1). Available from: https://www.pagepress.org/journals/hmr/article/view/533